MCOs New CEO first day on the job.Mike had previously undertaken some consultancy work for MCO but now has the role of the CEO.Be good to see the 2 New directors start buying some shares over the next few Months, backing themselves.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%